Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world antiviral therapy in pediatric immune clearance chronic hepatitis B
ChiCTR2400087708Phase 4Recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- May 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of interferon alfa in Chronic Hepatitis B (CHB) (3 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoint: HBsAg negative conversion rate (clinical cure rate). Started May 2024; status: recruiting.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400087708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087708.